Adient
ADNT · NYSE · Consumer Discretionary · United States
Delayed · as reported by Yahoo Finance · as of Jul 22, 2026, 7:30 PM
Financials at a glance
Source: SEC XBRLAnnual
Quarterly · last 8
Market cap
$1.6B
Day change
+2.6%
Fwd P/E
6.2
P/B
0.9
Beta
1.53
Revenue (FY2025)
$14.5B
Net margin
-1.9%
ROE
-15.9%
Revenue CAGR (2y)
-2.8%
EPS (FY2025)
-3.39
Net profit (FY2025)
$-281.0M
Market figures: Delayed · as reported by Yahoo Finance. Financials as reported in company filings.
Ask MarketChacha about ADNT
Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.
Financials
Yearly
| Period | Revenue | Net profit | EPS | Net margin | ROE |
|---|---|---|---|---|---|
| FY2025 | $14.5B | $-281.0M | -3.39 | -1.9% | -15.9% |
| FY2024 | $14.7B | $18.0M | 0.20 | 0.1% | 0.8% |
| FY2023 | $15.4B | $205.0M | 2.15 | 1.3% | 9.2% |
Quarterly
| Period | Revenue | Net profit | EPS | Net margin |
|---|---|---|---|---|
| 2026Q1 | $3.9B | $27.0M | 0.34 | 0.7% |
| 2025Q4 | $3.6B | $-22.0M | -0.28 | -0.6% |
| 2025Q2 | $3.7B | $36.0M | 0.43 | 1.0% |
| 2025Q1 | $3.6B | $-335.0M | -3.99 | -9.3% |
| 2024Q4 | $3.5B | $0 | 0.00 | 0.0% |
| 2024Q2 | $3.7B | $-11.0M | -0.12 | -0.3% |
| 2024Q1 | $3.8B | $-70.0M | -0.77 | -1.9% |
| 2023Q4 | $3.7B | $20.0M | 0.21 | 0.5% |
| 2023Q2 | $4.1B | $73.0M | 0.77 | 1.8% |
| 2023Q1 | $3.9B | $-15.0M | -0.16 | -0.4% |
Figures as reported, in reporting currency. Source: SEC XBRL.
Filings & announcements
2026
- SEC7/10/2026material
- SEC5/20/2026material
- SEC5/6/2026material
- SEC5/6/2026
In the news
- Quantedge Capital Pte Ltd Sells 377,200 Shares of Adient $ADNTMarketBeat · 7/22/2026
- Adient (ADNT) Could Be 38% Undervalued Following CFO Transitionsimplywall.st · 7/20/2026
- Stifel cuts Adient stock price target to $26 on margin concernsInvesting.com UK · 7/20/2026
- Adient (NYSE:ADNT) Price Target Cut to $26.00 by Analysts at Stifel NicolausMarketBeat · 7/20/2026
- Analysts’ Opinions Are Mixed on These Consumer Cyclical Stocks: Tesla (TSLA) and Adient (ADNT)The Globe and Mail · 7/16/2026
- J.P. Morgan Remains a Hold on Adient (ADNT)The Globe and Mail · 7/13/2026
- Is Adient (ADNT) A Bargain As Its CFO Exit Puts Valuation In Focus?simplywall.st · 7/13/2026
- Adient (NYSE:ADNT) Receives Consensus Recommendation of "Hold" from AnalystsMarketBeat · 7/12/2026
Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed · as reported by yahoo finance) are delayed and shown for reference only. Verify with the linked sources before acting.